Cargando…
Spotlight on tavaborole for the treatment of onychomycosis
Onychomycosis is a fungal nail plate infection that has been increasing in prevalence. A variety of oral and topical anti-fungal agents are currently available but their use is limited by their adverse effect profile, drug–drug interactions, and limited efficacy. Therefore, there is a great need for...
Autores principales: | Jinna, Sphoorthi, Finch, Justin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662369/ https://www.ncbi.nlm.nih.gov/pubmed/26640371 http://dx.doi.org/10.2147/DDDT.S81944 |
Ejemplares similares
-
An upcoming drug for onychomycosis: Tavaborole
por: Sharma, Neha, et al.
Publicado: (2015) -
Drug synergy discovery of tavaborole and aminoglycosides against Escherichia coli using high throughput screening
por: Liu, Shasha, et al.
Publicado: (2022) -
Efinaconazole in the treatment of onychomycosis
por: Lipner, Shari R, et al.
Publicado: (2015) -
Treatment of Onychomycosis: An Update
por: Shirwaikar, A. A., et al.
Publicado: (2008) -
Fungicidal Activity in the Presence of Keratin as an Important Factor Contributing to In Vivo Efficacy: A Comparison of Efinaconazole, Tavaborole, and Ciclopirox
por: Tachibana, Haruki, et al.
Publicado: (2017)